Zantac Lawsuit Update April 2022 | Zantac Lawsuit Payout Info

In early 2020 it was revealed that the popular heartburn medication Zantac contained a cancer-causing chemical.

NDMA, scientifically known as N-nitrosodimethylamine, is an organic compound that has been linked to numerous types of cancer including:

• Bladder cancer
• Pancreatic cancer (pancreatitis)
• Stomach cancer
• Brain cancer
• And other cancers

Research found NDMA in Zantac’s active ingredient, Ranitidine.

The U.S. Food and Drug Administration (FDA) warning says NDMA was found at levels between 3,000 to 26,000 times higher than FDA approved standards.

These high levels of NDMA put users at a higher risk of cancer.

The FDA acceptable threshold of daily NDMA intake is set at below 100 nanograms. The plaintiffs cited a study that claims that a 150-milligram pill of Zantac contains over 2.5 million nanograms of NDMA.

The FDA formally recalled and requested the removal of all Ranitidine products from shelves, and now the producers of Ranitidine and Zantac face lawsuits from hundreds of thousands of claimants.

Zantac MDL bellwether trials are estimated to take place in summer 2023.

The first Zantac trial will be brought in front of a jury on October 10, 2022 under California’s version of multidistrict litigation, called Judicial Council Coordinated Proceedings (JCCP).

The California trial will be a good indication on how bellwether trials in the Zantac MDL may pan out.

Research revealed that the primary active ingredient in Zantac and similar generic products, ranitidine, contains high levels of NDMA, a possible chemical carcinogen.

NDMA, scientifically known as N-nitrosodimethylamine, is an organic compound found at low levels in:

• Different foods
• Tobacco
• Shampoos
• Cleaning agents
• And other products

Scientists have found high levels of NDMA, according to FDA standards, in multiple pharmaceuticals which have consistently exposed consumers to the chemical.

Manufacturers failed to warn consumers that Zantac contained NDMA, putting consumers at risk of cancer.

FDA Warning – Ranitidine Products Containing NDMA Poses Cancer Risk

The U.S. Food and Drug Administration (FDA) reported an advisory on September 13, 2019, after discovering the carcinogenic contaminant NDMA in ranitidine, the active ingredient in Zantac, at levels between 3,000 to 26,000 times higher than FDA approved standards.

These high levels of NDMA put users at a higher risk of cancer.

The FDA acceptable threshold of daily NDMA intake is set at below 100 nanograms.

The plaintiffs cited a study that claims that a 150-milligram pill of Zantac contains over 2.5 million nanograms of NDMA.

Over-the-counter Zantac is typically sold in 150-milligram tablets - the recommended dosage to treat peptic ulcer disease for adults is 300 milligrams a night for four to eight weeks.

Plaintiffs allege that Sanofi and Boehringer Ingleham knew the risks of NDMA formation in ranitidine and did not alert the public through the drug’s label or through any other means.

Several published studies have shown that generic ranitidine users have a 400-fold increase of NDMA concentration in their urine.

The suit attests that had consumers known the risks, they would not have purchased or consumed ranitidine.

9 RANITIDINE PRODUCTS CONTAINING NDMA

These are the nine (9) most common Zantac products and generic Zantac products containing ranitidine:

• Zantac 150 Tablets
• Zantac 150 Maximum Strength
• Zantac 150 Maximum Strength Cool Mint
• Zantac 75 Tablets
• Wal-Zan 150
• Wal-Zan 75
• Heartburn Relief
• Acid Reducer
• Acid Control

Zantac and other ranitidine-containing products may put consumers at risk of a number of adverse health risks including cancer.

Zantac Injuries

NDMA, n-nitrosodimethylamine, is a potential hepatotoxic, and exposure has been linked to numerous serious complications and symptoms ranging from:

• Cancer
• Liver fibrosis and scarring
• Tumors in the liver, kidneys, and lungs

Other symptoms of NDMA exposure include:

• Headaches
• Fever
• Nausea
• Jaundice
• Vomiting
• Abdominal cramps
• Enlarged liver
• Dizziness
• Reduced function of the liver, kidneys, and lungs.

The World Health Organization described NDMA as a chemical that is “clearly carcinogenic.”

The FDA is working alongside regulators and industry partners to discover the source of impurities in ranitidine.

The FDA is examining ranitidine NDMA levels and evaluating the potential risk to patients.

The investigation is ongoing, and the agency plans to take appropriate measures.

Types Of Cancers Linked To Zantac

Plaintiffs in the Zantac suit have a variety of cancers, including:

• Bladder Cancer
• Brain Cancer
• Breast Cancer
• Esophageal/Nasal/Throat Cancer
• Intestinal Cancer
• Kidney Cancer
• Liver Cancer
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer
• Stomach Cancer
• Testicular Cancer
• Thyroid Cancer
• Uterine Cancer
• Other Cancers

The FDA issued a recall of all prescription and over-the-counter versions of Zantac in April 2020.

After determining the high levels of NDMA to be dangerous to consumers, the FDA called for patients to stop taking ranitidine.

Further, the FDA has requested that the manufacturers recall the product and discontinue production of both Zantac and generic Zantac drugs.

Prior to this decision, some companies such as CVS, Walmart, and Sandoz have chosen to voluntarily suspend the sales of Zantac while waiting for results from ongoing tests and research.

Both class-action lawsuits and civil lawsuits have been filed against the manufacturers of Zantac.

These are separate types of lawsuits.

It is important that you recognize which legal action is most appropriate for you before pursuing a Zantac lawsuit.

For assistance in determining your best legal action, contact TorHoerman Law for a free, no-obligation case consultation.

Zantac Class-Action Lawsuit

The makers of Zantac, a popular over-the-counter and prescription heartburn medication, are facing a Zantac class-action lawsuit claiming the drug contains unsafe levels of the cancer-causing substance N-Nitrosodimethylamine (NDMA).

The FDA reported an advisory on September 13, 2019, after discovering the carcinogenic contaminant NDMA in ranitidine, the active ingredient in Zantac, at levels between 3,000 to 26,000 times higher than FDA approved standards.

NDMA is a potential hepatotoxic, and exposure has been linked to numerous complications and symptoms including, but not limited to:

• Bladder cancer
• Stomach cancer
• Liver fibrosis and scarring
• Tumors in the liver, kidneys, and lungs

Other symptoms of NDMA exposure include:

• Headaches
• Fever
• Nausea
• Jaundice
• Vomiting
• Abdominal cramps
• Enlarged living
• Dizziness
• Reduced function of the liver, kidneys, and lungs

Plaintiffs accuse drugmakers Sanofi and Boehringer Ingelheim of manufacturing and marketing a medication they knew, or should have known, to be contaminated with the cancer-causing chemical without disclosing the risks to consumers or the government.

The CAL has been filed against the manufacturers for concealing adverse health risks associated with Zantac that led plaintiffs to suffer serious injury and death.

NOTICE: TorHoerman Law is not involved in the Zantac CAL.

The makers of Zantac, a popular heartburn medication, are facing lawsuits claiming the drug contains unsafe levels of the cancer-causing substance N-Nitrosodimethylamine (NDMA) which caused plaintiffs to develop cancer.

Plaintiffs accuse drugmakers Sanofi and Boehringer Ingelheim of manufacturing and marketing a medication they knew, or should have known, to be contaminated with the cancer-causing chemical without disclosing the risks to consumers or the government.

The manufacturer’s failure to warn directly lead to plaintiffs developing a number of life-threatening types of cancer after taking Zantac.

A Zantac MDL has been filed on behalf of individuals who have been diagnosed with cancer as a result of taking Zantac.

All similar Zantac cancer lawsuits will be consolidated into this MDL.

Notice: TorHoerman Law is involved in the Zantac Cancer Lawsuit.

Our firm is currently accepting new clients for the Zantac Lawsuit.

If you believe that you have a case, contact TorHoerman Law for a free, no-obligation case consultation with an experienced Zantac Lawyer.

You can also use our chatbot to receive a free, instant online case evaluation right now.

Which type of Zantac Lawsuit should you file?

Zantac Class-Action Lawsuit

If you took Zantac consistently and did not develop cancer, but were unaware of the cancer risks associated with Zantac, you may be eligible to participate in the Zantac CAL.

This lawsuit will likely compensate a percentage of the money you paid over time for Zantac products.

The award will be split evenly amongst class members.

Zantac Cancer Lawsuit

If you took Zantac and were subsequently diagnosed with cancer, you may qualify for a lawsuit.

The Zantac Lawsuit will compensate a percentage of the total damages that you incurred as a result of your cancer diagnosis, including but not limited to:

• Medical bills
• Lost income
• Future medical bills
• Future lost income
• Pain & suffering
• Loss of enjoyment of life
• Loss of life
• Other losses

The award will reflect your personal losses.

TorHoerman Law is currently accepting new clients in the Zantac Cancer Lawsuit.

Our firm is not currently accepting new clients in the Zantac CAL.

A lawsuit has been filed claiming that Zantac containing NDMA caused plaintiffs to develop cancer, which was not a health risk listed on the Zantac warning label.

Before filing a Zantac lawsuit, you should familiarize yourself with the steps of the civil litigation process so that you are aware of the process of a Zantac lawsuit.

Here are five (5) steps you should take when filing a Zantac Lawsuit:

1. Mitigating Damages

You should do everything possible to mitigate your injuries.

Steps to mitigate damages include:

• Seeking proper medical care
• Getting a diagnosis for injuries
• Following the doctor’s orders
• Doing everything in your power to minimize the costs and losses associated with injuries

Mitigation is extremely important in the process of building a strong and honest case with facts.

2. Hiring a Zantac Lawsuit Lawyer

The first step after mitigation is hiring a personal injury attorney who has experience handling bad drug lawsuits, such as the Zantac Lawsuit.

In the unfortunate event that you are representing a loved one who has died as a result of injuries from Zantac, you may need to consult with a wrongful death attorney who has knowledge of Zantac lawsuits.

Your experienced Zantac Lawsuit lawyer will work to:

• Gather evidence
• Establish liability
• Assess damages
• Navigate the litigation process
• Get you compensated for your losses

3. Understand the Zantac Lawsuit Statute of Limitation

The statute of limitations bar the amount of time that an injured party has to take legal action following an injury or accident.

The Zantac Lawsuit Statute of Limitations differ by:

• Type of Zantac litigation
• The state in which the case is filed
• The type of injury

Generally, a Zantac lawsuit plaintiff has 2 years to file a lawsuit following his or her cancer diagnosis.

However, this is not always the case.

It is best to consult with an attorney as soon as possible to determine your Zantac injury statute of limitations.

4. Gather Evidence

Evidence will help to prove the total cost of losses that you endured as a result of your injury, also known as your damages.

Your attorney will assist you in gathering evidence, but it is helpful if you start gathering evidence yourself as soon as you find out about your injury.

Common types of evidence in Zantac lawsuits include:

• Receipts of purchase of Zantac
• Medical records & bills
• Personal accounts of injury, such as journals
• Photos & videos of injury progression
• Proof of time off from work
• Proof of other costs associated with injury

5. Assess Damages

Damages are the total losses, both non-economic and economic, that an injured party incurs as a result of their injury.

In many personal injury lawsuits, the injured party will choose to file for both compensatory damages and punitive damages.

After assessing all damages that you incurred, your Zantac attorney will file a complaint demanding compensation to repay your damages.

Common damages in Zantac Lawsuits include:

• Medical expenses resulting from injuries
• Future medical expenses resulting from the injuries
• Pain and suffering, both physical and mental, caused by the injuries, treatment, and recovery period
• Wage loss, loss of earning capacity
• Other costs associated with our injuries
• Loss of enjoyment of life resulting from damages
• Loss of life
• Punitive damages against the manufacturer

At TorHoerman Law, our team of Zantac lawyers is available any time to discuss the Zantac Lawsuits.

We offer free no-obligation case consultations for all potential clients.

Our services are based on contingency fees, so we never charge our clients a dime until they have received compensation first.

With over 100 years in combined litigation experiences and client awards exceeding $4 billion in verdicts & negotiated settlements for litigations we have been involved in - we let our experience and results speak for themselves.

Contact TorHoerman Law to talk to experienced Zantac lawyers and learn about your legal options, including filing a Zantac cancer lawsuit.